Cinctive Capital Management LP Cuts Position in Agilent Technologies, Inc. $A

Cinctive Capital Management LP reduced its position in Agilent Technologies, Inc. (NYSE:A) by 12.3% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 72,856 shares of the medical research company’s stock after selling 10,196 shares during the period. Cinctive Capital Management LP’s holdings in Agilent Technologies were worth $9,351,000 as of its most recent SEC filing.

A number of other institutional investors have also modified their holdings of A. Envestnet Asset Management Inc. lifted its holdings in shares of Agilent Technologies by 3.8% during the 3rd quarter. Envestnet Asset Management Inc. now owns 607,914 shares of the medical research company’s stock valued at $78,026,000 after acquiring an additional 22,498 shares in the last quarter. CCLA Investment Management boosted its position in Agilent Technologies by 10.5% during the 3rd quarter. CCLA Investment Management now owns 1,027,970 shares of the medical research company’s stock worth $131,909,000 after purchasing an additional 97,312 shares during the period. Osaic Holdings Inc. increased its holdings in Agilent Technologies by 35.5% in the 2nd quarter. Osaic Holdings Inc. now owns 68,053 shares of the medical research company’s stock valued at $8,017,000 after purchasing an additional 17,817 shares in the last quarter. Fenimore Asset Management Inc increased its holdings in Agilent Technologies by 224.2% in the 3rd quarter. Fenimore Asset Management Inc now owns 586,500 shares of the medical research company’s stock valued at $75,277,000 after purchasing an additional 405,620 shares in the last quarter. Finally, First Horizon Corp purchased a new position in Agilent Technologies in the third quarter valued at about $1,378,000. Hedge funds and other institutional investors own 87.41% of the company’s stock.

Analyst Ratings Changes

A number of brokerages have commented on A. The Goldman Sachs Group began coverage on Agilent Technologies in a research note on Tuesday, December 9th. They set a “buy” rating and a $170.00 price objective on the stock. Robert W. Baird raised their target price on Agilent Technologies from $142.00 to $165.00 and gave the company an “outperform” rating in a report on Tuesday, November 25th. UBS Group reduced their price target on Agilent Technologies from $180.00 to $165.00 and set a “buy” rating on the stock in a research report on Thursday, February 26th. Evercore upgraded Agilent Technologies from an “in-line” rating to an “outperform” rating and upped their price target for the stock from $155.00 to $160.00 in a report on Monday, January 5th. Finally, Morgan Stanley lowered their price objective on shares of Agilent Technologies from $180.00 to $160.00 and set an “overweight” rating for the company in a research report on Tuesday, March 3rd. Two analysts have rated the stock with a Strong Buy rating, eleven have issued a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $161.20.

Agilent Technologies Stock Performance

NYSE:A opened at $111.60 on Friday. The firm has a 50-day moving average of $130.34 and a two-hundred day moving average of $135.83. The company has a debt-to-equity ratio of 0.44, a current ratio of 2.07 and a quick ratio of 1.59. The stock has a market cap of $31.54 billion, a P/E ratio of 24.64, a PEG ratio of 2.35 and a beta of 1.31. Agilent Technologies, Inc. has a 1-year low of $96.43 and a 1-year high of $160.27.

Agilent Technologies (NYSE:A) last announced its earnings results on Wednesday, February 25th. The medical research company reported $1.36 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.37 by ($0.01). Agilent Technologies had a return on equity of 24.49% and a net margin of 18.26%.The business had revenue of $1.80 billion for the quarter, compared to analysts’ expectations of $1.81 billion. During the same period in the previous year, the firm posted $1.31 earnings per share. The firm’s revenue was up 7.0% compared to the same quarter last year. Agilent Technologies has set its FY 2026 guidance at 5.900-6.040 EPS and its Q2 2026 guidance at 1.390-1.420 EPS. On average, research analysts expect that Agilent Technologies, Inc. will post 5.58 earnings per share for the current fiscal year.

Agilent Technologies Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 22nd. Shareholders of record on Tuesday, March 31st will be issued a dividend of $0.255 per share. The ex-dividend date is Tuesday, March 31st. This represents a $1.02 annualized dividend and a yield of 0.9%. Agilent Technologies’s payout ratio is currently 22.52%.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.